Browsing by Author "Castañeda, Carmen Paz"

Now showing 1 - 4 of 4
  • No Thumbnail Available
    Item
    Effects of socioeconomic status in cognition of people with schizophrenia: Results from a Latin American collaboration network with 1175 subjects
    (2021) Sanguinetti Czepielewski, Letícia; Alliende Serra, Luz María; Castañeda, Carmen Paz; Castro, Mariana; Guinjoan, Salvador M.; Massuda, Raffael; Berberian, Arthur A.; Fonseca, Ana Olivia; González-Valderrama A.; Gadelha, Ary; Bressan, Rodrigo; Crivelaro, Marisa; Louzã, Mario; Undurraga, Juan; González-Valderrama, Alfonso; López-Jaramillo, Carlos; Nieto, Rodrigo R.; Montes, Cristián; Silva, Henán; Langer, Álvaro I.; Valencia-Echeverry, Johanna; López-Jaramillo, Carlos; Solís-Vivanco, Rodolfo; Reyes-Madrigal, Francisco; Fuente-Sandoval, Camilo de la; Crossley, Nicolás A.; Gama, Clarissa S.
    Background Cognition heavily relies on social determinants and genetic background. Latin America comprises approximately 8% of the global population and faces unique challenges, many derived from specific demographic and socioeconomic variables, such as violence and inequality. While such factors have been described to influence mental health outcomes, no large-scale studies with Latin American population have been carried out. Therefore, we aim to describe the cognitive performance of a representative sample of Latin American individuals with schizophrenia and its relationship to clinical factors. Additionally, we aim to investigate how socioeconomic status (SES) relates to cognitive performance in patients and controls. Methods We included 1175 participants from five Latin American countries (Argentina, Brazil, Chile, Colombia, and Mexico): 864 individuals with schizophrenia and 311 unaffected subjects. All participants were part of projects that included cognitive evaluation with MATRICS Consensus Cognitive Battery and clinical assessments. Results Patients showed worse cognitive performance than controls across all domains. Age and diagnosis were independent predictors, indicating similar trajectories of cognitive aging for both patients and controls. The SES factors of education, parental education, and income were more related to cognition in patients than in controls. Cognition was also influenced by symptomatology. Conclusions Patients did not show evidence of accelerated cognitive aging; however, they were most impacted by a lower SES suggestive of deprived environment than controls. These findings highlight the vulnerability of cognitive capacity in individuals with psychosis in face of demographic and socioeconomic factors in low- and middle-income countries.
  • No Thumbnail Available
    Item
    Imaging social and environmental factors as modulators of brain dysfunction: time to focus on developing, non-Western societies
    (2019) Crossley Karmelic, Nicolas Andres; Alliende Serra, Luz Maria; Ossandón Valdés, Tomás; Castañeda, Carmen Paz; González-Valderrama, Alfonso; Undurraga, Juan; Castro, Mariana; Guinjoan, Salvador; Diaz-Zuluanga, Ana María; Pineda Zapata, Julian A.; Lopez-Jaramillo, Carlos; Reyes-Madrigal, Francisco; De la fuente Sandoval, Camilo; León-Ortíz, Pablo; Sanguinetti Czepielewski, Leticia; Gama, Clarissa S.; Zugman, Andre; Gadelha, Ary; Jackowski, Andrea; Bressan, Rodrigo
    Social and environmental factors are known risk factors and modulators of mental health disorders. We here conducted a nonsystematic review of the neuroimaging literature studying the effects of poverty, urbanicity, and community violence, highlighting the opportunities of studying non-Western developing societies such as those in Latin America. Social and environmental factors in these communities are widespread and have a large magnitude, as well as an unequal distribution, providing a good opportunity for their characterization. Studying the effect of poverty in these settings could help to explore the brain effect of economic improvements, disentangle the effect of absolute and relative poverty, and characterize the modulating impact of poverty on the underlying biology of mental health disorders. Exploring urbanicity effects in highly unequal cities could help identify the specific factors that modulate this effect as well as examine a possible dose-response effect by studying megacities. Studying brain changes in those living among violence, which is particularly high in places such as Latin America, could help to characterize the interplay between brain predisposition and exposure to violence. Furthermore, exploring the brain in an adverse environment should shed light on the mechanisms underlying resilience. We finally provide examples of two methodological approaches that could contribute to this field, namely a big cohort study in the developing world and a consortium-based meta-analytic approach, and argue about the potential translational value of this research on the development of effective social policies and successful personalized medicine in disadvantaged societies.
  • No Thumbnail Available
    Item
    Predictors of clozapine discontinuation at 2 years in treatment-resistant schizophrenia
    (ELSEVIER, 2021) Iruretagoyena Bruce Barbara Arantzazu; Castañeda, Carmen Paz; Mena, Cristian; Diaz, Camila; Nachar, Ruben; Ramirez Mahaluf Juan Pablo; González Valderrama, Alfonso; Undurraga, Juan; Maccabe, James H; Crossley, Nicolas A
    Little is known about predictors of clinical response to clozapine treatment in treatment-resistant psychosis. Most published cohorts are small, providing inconsistent results. We aimed to identify baseline clinical predictors of future clinical response
  • Thumbnail Image
    Item
    Uso de cannabis en jóvenes hospitalizados por un primer episodio de psicosis: un estudio caso-control
    (2020) Castañeda, Carmen Paz; Alliende Correa, Luz María; Iruretagoyena, Bárbara; Nachar, Rubén; Mancilla, Felipe; Diaz, Camila; Gallardo, Carlos; Mena, Cristian; Ramírez Mahaluf, Juan Pablo; Undurraga, Juan; González Valderrama, Alfonso; Crossley, Nicolás
    Background: Cannabis use among young people in Chile has increased significantly in the last years. There is a consistent link between cannabis and psychosis. Aim: To compare cannabis use in patients with a first episode of psychosis and healthy controls. Material and Methods: We included 74 patients aged 20 +/- 3 years (78% males) admitted to hospital with a first episode of psychosis and a group of 60 healthy controls aged 23 +/- 4 years (63% males). Cannabis consumption was assessed, including age of first time use and length of regular use. Results: Patients with psychosis reported a non-significantly higher frequency of life-time cannabis use. Patients had longer periods of regular cannabis use compared with healthy subjects (Odds ratio [OR] 2.4; 95% confidence intervals [CI] 1.14-5.05). Patients also used cannabis for the first time at an earlier age (16 compared with 17 years, p < 0.0). The population attributable fraction for regular cannabis use associated with hospital admissions due to psychosis was 17.7% (95% CI 1.2-45.5%). Conclusions: Cannabis use is related to psychosis in this Chilean group of patients. This relationship is stronger in patients with early exposure to the drug and longer the regular use. One of every five admissions due to psychosis is associated with cannabis consumption. These data should influence cannabis legislation and the public policies currently being discussed in Chile.